Production Animals held a 62.08% share of the veterinary pain management market in 2025, reflecting the segment’s established role in routine livestock care and commercial herd health management. its position is supported by the practical need to manage pain across large animal populations where treatment decisions are closely tied to animal welfare, recovery time, and productivity outcomes. In the veterinary pain management market, production animal use remains broad because pain control is embedded in standard treatment protocols for injury, illness, and post-procedural care across managed farm settings.

Companion Animals are the fastest-growing segment in the veterinary pain management market as pet care increasingly shifts toward more active clinical management of pain in dogs, cats, and other household animals. Growth is being reinforced by rising treatment acceptance among pet owners and a stronger focus on quality-of-life considerations, which supports more frequent use of pain management during chronic care, surgery recovery, and age-related conditions. Compared with production animals, the companion animal segment is gaining momentum through more individualized treatment decisions and greater willingness to pursue sustained veterinary care.

Mode of Purchase Segment Analysis: Prescription (Largest Segment) vs OTC (Fastest-Growing Segment)

With a 79.85% share in 2025, Prescription was the leading mode of purchase in the veterinary pain management market, underscoring the controlled and clinically supervised nature of many pain therapies used in animals. This dominance is sustained by the need for veterinary oversight in selecting appropriate drugs, dosing, and treatment duration, especially where species differences, condition severity, and safety considerations materially affect outcomes. The veterinary pain management market continues to rely heavily on prescription access because many effective pain interventions are closely tied to professional diagnosis and ongoing case management.

OTC is the fastest-growing mode of purchase in the veterinary pain management market, encouraged by demand for more accessible pain relief options in situations where owners seek quicker, lower-barrier care pathways. Its momentum relative to prescription products comes from convenience and the expanding role of owner-led health management for less complex pain concerns, particularly when immediate veterinary intervention is not the first step. As awareness of animal comfort rises, OTC purchasing is benefiting from the market’s shift toward easier access and broader day-to-day pain support.